yield10 bioscience, inc., an agricultural bioscience company, engages in developing disruptive technologies for step-changing improvements in crop yield in the united states and canada. the company, through its trait factory, is involved in developing high value seed traits for the agriculture and food industries. it also has an oilseed development center in saskatchewan, canada. yield10 bioscience, inc. has research agreements with bayer ag to develop traits in soybean; forage genetics international, llc to develop traits in forage sorghum; j. r. simplot company to develop novel traits in potato; and gdm seeds inc. to evaluate yield traits in soybeans. the company was formerly known as metabolix, inc. and changed its name to yield10 bioscience, inc. in january 2017. yield10 bioscience, inc. was founded in 1992 and is headquartered in woburn, massachusetts.
Company profile
Ticker
YTEN
Exchange
Website
CEO
Oliver Peoples
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
METABOLIX INC, METABOLIX, INC.
SEC CIK
Corporate docs
Subsidiaries
Yield10 Bioscience Securities Corp. • Metabolix Oilseeds, Inc. ...
IRS number
43158289
YTEN stock data
Latest filings (excl ownership)
8-K
Changes in Registrant's Certifying Accountant
26 Feb 24
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
16 Feb 24
8-K
Other Events
14 Feb 24
8-K
Yield10 Bioscience Provides an Update on its Omega-3 Camelina Program
8 Feb 24
8-K
Changes in Registrant's Certifying Accountant
5 Feb 24
8-K
Cost Associated with Exit or Disposal Activities
6 Dec 23
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
17 Nov 23
8-K
USDA-APHIS Determines that Yield10 Bioscience’s Glufosinate Tolerant Camelina May Be Planted and Bred in the United States
15 Nov 23
8-K
Yield10 Bioscience Announces Third Quarter 2023 Financial Results
14 Nov 23
10-Q
2023 Q3
Quarterly report
14 Nov 23
Transcripts
YTEN
Earnings call transcript
2023 Q3
14 Nov 23
YTEN
Earnings call transcript
2023 Q2
14 Aug 23
YTEN
Earnings call transcript
2023 Q1
10 May 23
YTEN
Earnings call transcript
2022 Q4
14 Mar 23
YTEN
Earnings call transcript
2022 Q3
14 Nov 22
YTEN
Earnings call transcript
2022 Q2
11 Aug 22
YTEN
Earnings call transcript
2022 Q1
12 May 22
YTEN
Earnings call transcript
2021 Q4
10 Mar 22
YTEN
Earnings call transcript
2021 Q3
11 Nov 21
YTEN
Earnings call transcript
2021 Q2
12 Aug 21
Latest ownership filings
Financial summary
Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 3.08 mm | 3.08 mm | 3.08 mm | 3.08 mm | 3.08 mm | 3.08 mm |
Cash burn (monthly) | (no burn) | 92.08 k | 1.24 mm | 1.20 mm | 870.33 k | 951.58 k |
Cash used (since last report) | n/a | 518.05 k | 6.99 mm | 6.76 mm | 4.90 mm | 5.35 mm |
Cash remaining | n/a | 2.56 mm | -3.91 mm | -3.68 mm | -1.82 mm | -2.27 mm |
Runway (months of cash) | n/a | 27.8 | -3.1 | -3.1 | -2.1 | -2.4 |
Institutional ownership, Q3 2023
29.8% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 19 |
Opened positions | 9 |
Closed positions | 4 |
Increased positions | 3 |
Reduced positions | 1 |
13F shares | Current |
---|---|
Total value | 194.43 mm |
Total shares | 3.57 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Schuler Jack W | 2.80 mm | $1.21 mm |
Cannell Peter B & Co | 258.84 k | $84.56 mm |
Lind Global Macro Fund | 150.68 k | $871.00 k |
Geode Capital Management | 62.50 k | $20.42 mm |
Millennium Management | 55.26 k | $18.06 mm |
Cutter & CO Brokerage | 50.00 k | $16.34 mm |
Warberg Asset Management | 40.99 k | $13.39 mm |
Vanguard | 40.45 k | $13.22 mm |
BLK Blackrock | 31.38 k | $10.25 mm |
Citadel Advisors | 26.56 k | $8.68 mm |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
15 Feb 24 | Haaser Charles B | Common Stock | Grant | Acquire A | No | No | 0.3 | 100,000 | 30.00 k | 110,302 |
15 Feb 24 | Peoples Oliver P | Common Stock | Grant | Acquire A | No | No | 0.3 | 200,000 | 60.00 k | 238,308 |
15 Feb 24 | Brum Lynne H | Common Stock | Grant | Acquire A | No | No | 0.3 | 100,000 | 30.00 k | 108,326 |
15 Feb 24 | Snell Kristi | Common Stock | Grant | Acquire A | No | No | 0.3 | 120,000 | 36.00 k | 129,022 |
29 Dec 23 | Sinskey Anthony J | Common Stock | Grant | Acquire A | No | No | 0 | 16,275 | 0.00 | 43,713 |
News
12 Health Care Stocks Moving In Monday's Pre-Market Session
11 Mar 24
12 Health Care Stocks Moving In Friday's After-Market Session
8 Mar 24
Yield10 Bioscience Grants Global License To VISION Bioenergy Oilseeds; $3M Cash Payments To Yield10
14 Feb 24
What's Going On With Yield10 Bioscience (YTEN) Stock?
8 Feb 24
Why Compass Minerals International Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
8 Feb 24
Press releases
Yield10 Bioscience Reports that Proprietary Varieties of Winter Camelina Show Tolerance to Commonly Used Herbicides in First Field Tests
29 Feb 24
Yield10 Bioscience Grants Global License to VISION Bioenergy Oilseeds for Herbicide Tolerant Camelina Cultivated for the Production of Biofuel Feedstock
14 Feb 24
Yield10 Bioscience Provides an Update on its Omega-3 Camelina Program
7 Feb 24
Yield10 Bioscience Files Request for Regulatory Status Review with USDA-APHIS for Camelina Designed to Produce the EPA and DHA Components of Omega-3 Oil
8 Jan 24